Company News

U.S. medical device company Royal Oak Medical Devices has been testing its so-called rep-less sales model. Now it’s to be rolled out across the country.

Baxano had better find a buyer pretty soon because the news that it has now filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code suggests it’s running out of runway.

The spin-off will create a new publicly traded company called SeaSpine, focused on developing, marketing and selling spine hardware and orthobiologics.

Zimmer Holdings, Inc., is offering us an advance preview of its future executive leadership team and organizational structure of what is to be called Zimmer Biomet.

Integra LifeSciences Holdings Corporation has completed the acquisition of the MicroFrance and Xomed instrument lines from Medtronic.

Covidien supports publicity initiative to drive earlier diagnosis of lung cancer, opening up treatment options and improved patient outcomes

Sorin Group has announced that it is to make a $20 million minority investment in Respicardia, a developer of implantable therapies to improve Respiratory Rhythm Management™.

A new injunction issued by a US district court, prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE®+7.

The family of the man who helped invent the ICD has been awarded $309 million against Boston Scientific, although appeals loom.

Staring down the barrel, standing on the brink. Call it what you like, but events have overtaken Echo Therapeutics’ efforts to keep the door open. Failing a last minute solution things look bad for the wireless glucose monitoring technologists.

Diagnostic and Monitoring company EXALENZ Bioscience has been named as one of the prestigious Deloitte Technology Fast 50, an annual ranking of the 50 fastest-growing technology companies in Israel for 2014.

Blue Belt Technologies Enters into a Commercial Agreement with DePuy Synthes to Support the SIGMA® HP Partial Knee System on the Navio® Surgical System

Legal-Bay LLC, tells us that a Federal Jury in West Virginia has awarded a husband and wife $3.27 million in damages against Ethicon, Johnson & Johnson’s mesh product division in what is another loss for transvaginal mesh manufacturers

J&J’s Codman Neuro tells us it has entered into an exclusive distribution agreement with Pulsar Vascular to market and promote the PulseRider® wide neck aneurysm device in Europe, the Middle East and Africa.

It’s full steam ahead for Claret Medical as it announces Series B financing that will take it a long way down the road to US FDA approval, assuming its pivotal study goes to plan.

Sounds like a plan. Combine the offerings of one of the Cardiovascular big boys with wire forming company’s expertise and FFR technology is likely to benefit.